News

The U.S. Food and Drug Administrated (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) status to AAV-GAD, MeiraGTx’s gene therapy for Parkinson’s disease, the company has announced. The designation was granted based on data from three clinical studies showing the treatment eased motor symptoms and improved the quality…

Hillhurst Biopharmaceuticals said it’s been awarded $6.3 million to fund a Phase 2a clinical study to test the efficacy of HBI-002, its low-dose liquid formulation of carbon monoxide, in preserving dopaminergic neurons, those that are lost to Parkinson’s disease, with the goal of slowing or stopping disease progression. The…

The first three patients treated with ANPD001, a cell therapy for Parkinson’s disease, showed reduced motor symptoms and improved daily functioning over six months, without any serious side effects. That’s according to early data from the Phase 1/2a ASPIRO (NCT06344026) study, an open-label clinical trial testing the…

Two University of Michigan-Flint doctorate students received a $50,000 grant to support diversity among exercise providers offering care to people with Parkinson’s disease. The grant, from The Michigan Health Equity Challenge, will help the pair’s Move to Represent initiative train 10 physical and occupational therapists of color to…

Using advanced diagnostic tools — such as different types of brain scans and methods that employ artificial intelligence (AI) — may help detect early signs of Parkinson’s that precede the onset of the disease’s motor symptoms, according to a new review study. The researchers noted that employing these AI-based…

Nerve cells in the brain that are responsible for processing smells and sight show deficits in Parkinson’s disease, according to research done in a mouse model. The findings may lay the groundwork for new approaches to diagnose Parkinson’s, according to scientists. “I think this work is a nice first…

Neuroimaging company Xingimaging has announced the launch of the NX PET Camera, a new tool for positron emission tomography (PET) imaging that aims to accelerate research into Parkinson’s disease. The novel tool, for use in PET imaging scans, “offers cutting-edge imaging capabilities, providing researchers with unparalleled precision in…

People who eat large amounts of highly processed foods are more likely to develop early Parkinson’s disease symptoms, a study found. “There’s growing evidence that diet might influence the development of Parkinson’s disease,” Xiang Gao, MD, PhD, co-author of the study and a professor at Fudan University in China, said…

A small molecule called NK036 — which inhibits USP30, an enzyme that counters the removal of damaged mitochondria from nerve cells in Parkinson’s disease — fits tightly into its target, suggesting it may have a strong and lasting effect as a treatment for the neurological condition, a new study…

The Michael J. Fox Foundation (MJFF) is expanding the size and reach of its global Edmond J. Safra Fellowship in Movement Disorders program, which trains specialists in improving access to Parkinson’s disease care. The program provides funding each year for medical centers to train physicians to become Parkinson’s specialists.